Healthcare

>

Drug Manufacturers—Specialty & Generic

>

OTC:
MYCOF

Mydecine Innovations Group Inc

Recent publications about $MYCOF

Mydecine To Attend March Investor Conferences

DENVER, March 03, 2022 (GLOBE NEWSWIRE) — Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming

Register by Email

or
Already a member? Sign In